U.S. markets open in 8 hours 54 minutes

Dr. Reddy's Laboratories Limited (RDY)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
66.00+0.99 (+1.52%)
At close: 4:00PM EDT
Sign in to post a message.
  • S
    S. G. Warsi
    Is it worth to buy Dr. Reddy's Laboratories today @ Rs. 3353 for 10 days waiting to sell it at profit of rupees 100 per share or it is not suggested?
  • Y
    Yahoo Finance Insights
    Dr Reddy's Laboratories is up 4.96% to 67.09
  • Y
    Yahoo Finance Insights
    DRREDDY.NS is up 5.01% to 4999.00
  • A
    Al
    Amarin Corporation plc
    $TEVA could not win the Patent / Generic case againest $AMRN in 2016 and had to settle. same thing will happen $RDY and $HKMPF on 01/13/2019 or earlier.
    Bullish
  • A
    Al
    Amarin Corporation plc
    Most probably $AMRN will settle the Patent / Generic case with $RDY and $HKMPF like what happened with $TEVA in the next week (the week of 01/06/2020) then sell itself the following week (the week of 01/13/2020). The deal will be announced during JP Morgan conference. $50-$70 pps
    Bullish
  • Y
    Yahoo Finance Insights
    Dr Reddy's Laboratories is down 5.01% to 62.55
  • J
    Judy
    $TEVA conversation
    These opioid cases are completely bogus and politically motivated going into election season. The FDA and Dr's should foot 50% clean u bill. People who abuse drugs should be responsible for the other 50% since they can't follow directions. $JNJ $TEVA $MYL $ENDP $RDY $PFE
  • M
    Master mind
    This stock goes down even after positive news?
  • S
    Swing
    Big day today lets gooooo!
  • G
    Geoffrey
    In India, people familiar with the development said the company is in discussions with Dr Reddys Laboratories, Cipla, Jubilant Lifesciences, and Strides Pharmaceuticals for granting them voluntary licences.
    In India, people familiar with the development said the company is in discussions with Dr Reddys Laboratories, Cipla, Jubilant Lifesciences, and Strides Pharmaceuticals for granting them voluntary licences.
    economictimes.indiatimes.com
  • H
    Henry_L
    $CELG conversation
    TradeHawk


    @TradeHawk
    7m7 minutes ago
    More
    $CELG $RDY Celgene popping on denial of institution of '717 Revlimid IPR patent challenge trial by Dr. Reddy Labs.
  • N
    Nope
    So what is the real inside story on this lawsuit with Amrin?
  • S
    Susan B
    Does Dr. Reddy's Laboratories produce the generic malaria drug they are looking at for Covid 19?
  • M
    Master mind
    Two big announcements in this week could drive this stock to 40 mere easily when trade war fear ends.
  • G
    Geoffrey
    Here is a link to the annual report. Not sure why the stock is down today. Everything increased relative to last year in the summary letter. There are several warnings about the impact of Covid-19, but nothing unexpected.

    https://www.bseindia.com/xml-data/corpfiling/AttachLive/8d02435d-aefd-43a0-bec9-5dcca31c5883.pdf
  • D
    Darren
    We should not allow third world drug companies to sell drug in the US. Not a shred of research and only drug companies that make discoveries should be allowed to manufacture generic drugs. US drug companies should setup license agreements with local drug manufacturers in under developed countries to help them develop their industry.
  • D
    Denis
    I made a video about Dr. Reddy's Laboratories($RDY)
    Check it on YouTube: https://www.youtube.com/watch?v=y9w5LUbskn8
    RDY Stock Analysis📈, is Dr. Reddy's Laboratories a BUY?
    www.youtube.com
  • B
    Bojan
    I wanted to share an article describing in details company and business outlook who is interested can check it https://finpedia.co/bin/Dr%20Reddy%27s%20Laboratories/
    Dr Reddy's Laboratories
    Dr Reddy's Laboratories
    finpedia.co
  • L
    LeslieKnope
    $AMRN conversation
    $RDY doesn't appear to be affected much by the ruling.
  • A
    Alagaesh
    as i told downtrend only